Park Ha Biological Technology Co. Ltd
(PHH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 583,000 | 963,000 | 953,000 | 1,315,000 | 1,153,000 |
| Receivables | 78,000 | 66,000 | 81,000 | 123,000 | 71,000 |
| TOTAL | $661,000 | $1,029,000 | $1,034,000 | $1,438,000 | $1,224,000 |
| Non-Current Assets | |||||
| PPE Net | 22,000 | 36,000 | 47,000 | 36,000 | 51,000 |
| Investments And Advances | 270,000 | 683,000 | 743,000 | 915,000 | 834,000 |
| Intangibles | 832,000 | 1,318,000 | 1,571,000 | 1,699,000 | 1,936,000 |
| Other Non-Current Assets | 26,000 | 109,000 | 247,000 | 208,000 | 4,808,000 |
| TOTAL | $1,150,000 | $2,146,000 | $2,608,000 | $2,858,000 | $7,629,000 |
| Total Assets | $1,811,000 | $3,175,000 | $3,642,000 | $4,296,000 | $8,853,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 605,000 | 773,000 | 251,000 | 244,000 | 281,000 |
| TOTAL | $605,000 | $773,000 | $251,000 | $244,000 | $281,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 370,000 | 1,262,000 | 1,348,000 | 1,739,000 | 2,024,000 |
| Other Non-Current Liabilities | 492,000 | 230,000 | 499,000 | 474,000 | 4,142,000 |
| TOTAL | $885,000 | $1,602,000 | $2,043,000 | $2,481,000 | $6,882,000 |
| Total Liabilities | $1,258,000 | $2,085,000 | $2,294,000 | $2,725,000 | $7,163,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,552 | 53,599 | 53,500 | 51,197 | 57,302 |
| Common Shares | N/A | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -3,000 | 214,000 | 416,000 | 566,000 | 507,000 |
| Other shareholders' equity | -9,000 | -10,000 | 20,000 | 15,000 | 40,000 |
| TOTAL | $553,000 | $1,090,000 | $1,348,000 | $1,571,000 | $1,690,000 |
| Total Liabilities And Equity | $1,811,000 | $3,175,000 | $3,642,000 | $4,296,000 | $8,853,000 |